Is ARDX Worth Buying in 2026?

Ardelyx, Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether Ardelyx, Inc. (ARDX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +40.2%. Concerns: 50-day MA is falling (-4.80% over 10 days); RSI 83 — overbought, elevated pullback risk. Currently 23.2% off its 52-week high. Score: +2/7.

Ready to act on this? 📈 Trade on Webull

ARDX is in a confirmed uptrend, trading above both its 50-day ($6.21) and 200-day ($5.89) moving averages. With an RSI of 83.5, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +40.2% compares to +35.1% for SPY (beat the market by 5.1%). The current 23.2% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $14,022 today
vs. S&P 500 (SPY) — same period beat market by 5.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($5.89)
Above 50-day MA ($6.21)
!RSI(14) neutral zone (30–70) — currently 83.5
Positive return (+40.2%)
!Within 10% of period high (−23.2%)
Period Range $6.45
$3.21 $8.40
RSI (14) 83.5
0 · OversoldOverbought · 100

Key Metrics

Price$6.45
Period Return+40.2%
Period High$8.40
Period Low$3.21
Drawdown−23.2%
MA-50$6.21
MA-200$5.89
RSI (14)83.5
Avg Volume (30d)3.2M
vs. SPYbeat by 5.1%
Return Rank#429 of 996

Trade ARDX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers